Healthcare industry

Press release - 04/08/2011

HARTMANN stands its ground in an increasingly difficult market

In the first half of 2011 the HARTMANN GROUP was confronted with an unfavorable market environment. Raw material and logistics costs continued to rise significantly in the overall economic recovery. Furthermore there has been added price pressure from customers due to the national deficits and the associated budget restrictions in the health systems. Nevertheless HARTMANN succeeded in further increasing sales revenues by 6.2 to EUR 845.3 million…

The Baden-Württemberg Ministry of Finance and Economics presented the results of two studies that evaluated the innovative strength of Baden-Württemberg in comparison to other regions around the world. The studies were carried out by the University of Hohenheim and the independent research institute BAK Basel Economics AG BAK Basel on behalf of the Baden-Württemberg Ministry of Finance and Economics and they were financed by the Baden-Württemberg…

Press release - 15/07/2011

HITS Participates in a new DFG Research Unit on Blood Coagulation

Scientists from the Heidelberg Institute for Theoretical Studies participate in a new Research Unit on blood coagulation sponsored by the German Research Foundation (DFG). The aim of the DFG funding is to support a successful existing cooperation between scientists over several years.

Article - 20/12/2010

Michael Reth – Immunobiological discoveries that meet resistance

Dr Michael Reth professor at the Max Planck Institute of Immunobiology and the University of Freiburg and some of his colleagues have recently uncovered the mechanism that foreign substances use to activate B cells of the immune system. The researchers were using synthetic biology methods long before this particular branch of science existed in its present form. Their results require a paradigm change and a revision of the reference books.

Guest article - 05/12/2010

Report from Jiangsu

Sandra Barudio a chemist from the University of Freiburg is currently doing four months practical training in the company GenePharma based in Suzhou Jiangsu province China. Barudio arrived in China at the beginning of September 2010 funded by a China grant from the Baden-Württemberg Ministry of Science Research and the Arts. She is a doctoral student in her second year at the Institute of Chemistry at Freiburg University and is doing her doctoral…

Nanjing Medicinal group a state-owned enterprise is among the top six pharmaceutical conglomerates in China. It is composed of 15 pharmaceutical companies and controls 1000 retail drugstores. A hospital and a research institute are also part of the group.

Press release - 16/11/2010

Nycomed is keeping the pace in third quarter 2010 - US Food & Drug Administration to decide on the approval of Daxas®

Nycomed’s strategy of focusing on emerging markets and specialty products is paying off. The third quarter results shows that the sales of Key Products and in emerging markets are continuing to help offset the impact from the loss of exclusivity of pantoprazole. Daxas® (roflumilast) has recently been launched in the first EU markets and further launches are underway over the coming months. To accelerate the expansion in China, one of the fastest…

Press release - 04/11/2010

Nycomed to acquire of majority stake in Guangdong Techpool Bio-Pharma

Nycomed today announced that it is significantly expanding its presence in China through the acquisition of a majority stake in Guangdong Techpool Bio-Pharma Co., Ltd. (Techpool), a fast-growing Chinese bio-pharmaceutical company based in Guangdong. Techpool, founded in 1993, specialises in the research, development, manufacturing and marketing of biologic drugs derived from natural sources.

Article - 03/10/2010

LimCo International - innovative methods to assess water pollution

LimCo International has developed the Multispecies Freshwater Biomonitor a unique continuous early warning system that enables the fully automated detection of water contamination. The companys GamTox toxicity test can be used to assess the ecological situation of flowing waters.

Press release - 09/09/2010

China Medical City, Taizhou

Taizhou is a commercial and industrial city of around 5 million inhabitants located in the Yantze River Delta about half way between Nanjing and Suzhou. Within the Taizhou city boundaries on a total area of 25 square kilometers China Medical City CMC a national-level pharmaceutical high-tech park is currently under construction.

Jiangnan University JU is one of Chinas key universities of the 211 Project and functions under the Ministry of Education. The university host the National Engineering Laboratory of Fermentation Technology the Key Laboratory of Industrial Biotechnology the Engineering Research Center of Bioactive Product Processing Jiangsu Province and the Collection of Industrial Microbes Resources.

Press release - 09/09/2010

C&O Pharmaceutical Technology (Holdings) Ltd., Nanjing

Headquartered in Hong Kong and listed on the Singapore Exchange since October 2005 CO Pharmaceutical Technology Holdings Limited CO is an integrated pharmaceutical group in the Peoples Republic of China. The business model spans the entire value chain in the pharmaceutical industry which includes Reasearch and Development RD manufacturing marketing and distribution of CO branded respectively third party pharmaceutical products.

Press release - 25/06/2010

Delegation trip to China – 30 years of scientific relations

The Baden-Württemberg Minister of Science Professor Dr. Peter Frankenberg and Secretary of State Dr. Dietrich Birk have returned from a delegation trip to the Chinese region of Shanghai. They were accompanied by representatives of Baden-Württemberg universities. Frankenberg and Birk used the trip to highlight the fact that China has been an important long-term partner to many universities in the state of Baden-Württemberg. During their trip the…

Press release - 23/06/2010

Technology park „bioBAY“ - life science infrastructure the Chinese way

Being one of Baden-Württemberg’s global partner regions, the Chinese province of Jiangsu deserves special attention in the field of life sciences. The highly dynamic bioBAY park located in the city of Suzhou puts a strong emphasis on bio- and nanotechnologies. With its numerous science and business opportunities bioBAY has a lot to offer also to potential partners from Baden-Württemberg.

Article - 12/06/2010

Correcting enzyme defects using stem cells

Bone marrow transplantation was originally developed for the treatment of leukaemias and other malignant diseases of the haemotopoietic system. Thanks to increasing technological process it has been possible to considerably expand the treatment spectrum over the last few years. Dr. Ingo Müller paediatrician at the University Hospital in Tübingen now uses bone marrow transplantation for the therapy of genetic metabolic diseases with highly…

Article - 15/04/2010

Molecular biomechanics or mechanobiochemistry

Frauke Gräter is head of the Molecular Biomechanics research group at the Institute for Theoretical Studies in Heidelberg. Gräter uses computer-based methods to investigate the mechanical forces acting on biological macromolecules in the nanometre range. Her team was also able to show that highly complex processes such as haemostasis are regulated by shear forces.

Press release - 17/03/2010

Bacterial balance that keeps us healthy

Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, working within the European project MetaHIT and in collaboration with colleagues at the Beijing Genomics Institute at Shenzhen, China, established a reference gene set for the human gut microbiome – a catalogue of the microbe genes present in the human gut. Their work proves that high-throughput techniques can be used to sequence environmental samples, and…

Article - 15/07/2009

The gap in the value creation chain

On a national level the University of Freiburg comes out reasonably well in comparison with other universities regarding the number of patents filed and licensed. But is it enough to protect an intellectual property and sell it to a company? No says Prof. Dr. Bernhard Arnolds from the Central Office of Research Funding and Technology Transfer at the University of Freiburg.

Article - 25/08/2008

Markers that reveal the correct biological age

Researchers at the University of Ulm have just identified a number of proteins that reveal the biological age of a person. These biomarkers might be used in medical applications to adapt the medical treatment of older people to their individual biological age.

How can a doctor reach a brain tumour with a scalpel? Stockert devices which use catheter technology and probes to localise and electrically neutralise problematic tissue help to solve the problem in hospitals all over the world.

Article - 17/06/2008

"Study and work abroad!”"

Quick practically oriented and above all international The new bachelor and masters degrees in the natural sciences have been introduced to bring German university qualifications into line with the requirements of the international job market as well as to facilitate the uncomplicated exchange of scientists across the globe. However not everything always works out as planned. Research abroad is often limited by time and money.

Nycomed announced the appointment of Guido Oelkers as the new Executive Vice President Commercial Operations. It is planned that he joins Nycomed in September 2008. Based in Zurich Guido Oelkers will be in charge of all Commercial Operations and its Area Managers with the exception of RussiaCIS.

Press release - 19/05/2008

Viruses caught red-handed

Prof. Thilo Stehle biochemist at the University of Tübingen wants to capture and accurately study the moment at which a virus binds to a cell. He is hoping that further insights into this process might some time enable the development of drugs.

In an independent market study by Ceresana Research the latest data facts and trends of the antioxidant market are analysed and presented. Data concerning the antioxidant market are subdivided by region based on value and quantity.

Press release - 07/05/2008

ChemCon – and how an ideal niche was found and occupied

At first sight the business idea seems somehow strange Who would deliberately choose to develop and produce pharmaceutical substances that are hardly required and if so only in small quantities. Dr. Raphael Vogler and Dr. Peter Gockel the founders and owners of Freiburg-based ChemCon GmbH have done exactly that - and found an ideal niche for their company. Even the largest companies of the industry are benefiting from ChemCons know-how and…